Dahe Zhang - Chief Financial Officer, Director, 10%+ Owner at CITIUS ONCOLOGY, INC.

Issuer-level insider activity

Role
Chief Financial Officer, Director, 10%+ Owner
Issuer ticker
CTOR on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Dahe Zhang since 26 Aug 2025

Reported holdings for Dahe Zhang in CITIUS ONCOLOGY, INC.

Form 4 holding Chief Financial Officer, Director, 10%+ Owner

TenX Keane Acquisition

Security class
Ordinary Shares
Shares / value
1,725,000
Estimated value
Report date
13 Oct 2022
Price
Ownership
By 10XYZ Holdings LP

Transaction history for Dahe Zhang in CITIUS ONCOLOGY, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .